Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.

Archives of pathology & laboratory medicine - 1 May 2022

Ramkissoon Shakti H, Fernandes Helen, Lopez-Terrada Dolores H, Hameed Meera R, Trembath Dimitri G, Bridge Julia A, Lindeman Neal I, Souers Rhona J, Vasalos Patricia, Brat Daniel J, Moncur Joel T

Abstract excerpt

CONTEXT.—: Integration of molecular data into glioma classification supports diagnostic, prognostic, and therapeutic decision-making; however, testing practices for these informative biomarkers in clinical laboratories remain unclear. OBJECTIVE.—: To examine the prevalence of molecular testing for clinically relevant biomarkers in adult and pediatric gliomas through review of a College of American Pathologists...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Central Nervous System Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Laboratory Techniques

Share to Glioma

Share to Mutation

Share to World Health Organization

Source

Identifiers

PMID: 35878398
DOI: 10.5858/arpa.2021-0431-CP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.PMID 35878398Read ↗

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.Semantic proximity Read ↗

2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.Semantic proximity Read ↗

The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.Semantic proximity Read ↗

Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?Semantic proximity Read ↗

The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.Semantic proximity Read ↗

Molecular pathology and clinical implications of diffuse glioma.Semantic proximity Read ↗

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity Read ↗

WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.Semantic proximity Read ↗

Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.Semantic proximity Read ↗

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaSemantic proximity Read ↗

Management of diffuse low-grade gliomas in adults — use of molecular diagnosticsSemantic proximity Read ↗

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.